Rubella in the Russian Federation: Epidemiological features and control measures to prevent the congenital rubella syndrome

Epidemiology and Infection

Volumn 125, Issue 2, 2000, Pages 359-366

  Semerikov, V V ^a,e   Lavrentyeva, I N ^b   Popov, V F ^c   Fletcher, M A ^d   Kolotov, M E ^e  

^a Centre of State Sanitary Epidemiological Surveillance   (Russian Federation)

^b ST PETERSBURG PASTEUR INSTITUTE   (Russian Federation)

^c Tarasevic State Institute for the Standardization and Control of Medical Biological Preparations   (France)

^d SANOFI PASTEUR   (France)

^e Aventis Pasteur   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN ALBUMIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RUBELLA ANTIBODY; RUBELLA VACCINE; SODIUM CHLORIDE; UNITHIOL; VIRUS HEMAGGLUTININ;

ADOLESCENT; ADULT; ARTICLE; BIRTH DEFECT; CHILD; CONGENITAL RUBELLA SYNDROME; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG EFFICACY; EPIDEMIOLOGICAL DATA; FEMALE; HEALTH PROGRAM; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; INCIDENCE; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; NONHUMAN; PREGNANCY DISORDER; PRENATAL CARE; PUBERTY; REVIEW; RUSSIAN FEDERATION; SEROLOGY; VACCINATION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; ANTIBODY FORMATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PREGNANCY; PRENATAL CARE; RUBELLA; RUBELLA SYNDROME, CONGENITAL; RUBELLA VACCINE; RUSSIA; SEROEPIDEMIOLOGIC STUDIES;

EID: 0033670980     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0950268899004343     Document Type: Article

References (41)

1. Rubella
2. Rubella morbidity in Leningrad and affect on groups at risk of rubella
3. Ways to prevent maternal and perinatal morbidity and mortality
4. Birth and death of congenital rubella syndrome
5. Rubella in the distant past as a possible cause of congenital malformations
6. Use of a combined epidemiological, virological and morphological analysis of rubella infection for an epidemiological survey of congenital rubella
7. Epidemiological basis of elimination of infections diseases
8. Vaccine prophylaxis-M
9. Changing epidemiology of congenital rubella syndrome in the United States
10. Rubella in Russia: The detection of congenital rubella and the vaccination strategy and procedures
11. Evaluation of Wistar RA27/3 rubella virus vaccine in children
12. History of RA27/3 rubella vaccine
13. Licensed vaccines
14. Epidemiological, microbiological and clinical problems of aerosol and intestinal infections
15. Preparations for specific prophylactics and diagnostics of measles, parotitis, and rubella
16. Present state and future of protective vaccinations
17. Quality and efficiency of antiepidemic measures
18. Measurement of rubella antibody by hemagglutination inhibition. II. Characteristics of an improved HAI test employing a new method for the removal of non-immunoglobulin HA inhibitors from serum
19. False-positive rubella virus hemagglutination inhibition reactions: Occurrences and disclosure
20. The derivation of minimum immune titre of rubella haemagglutination-inhibition (HI) antibody. A public health laboratory service collaborative survey
21. Outcome of asymptomatic infection with rubella virus during pregnancy
22. Attenuation of RA27/3 rubella virus in WI-38 human diploid cells
23. Production of RA27/3 rubella vaccine and clinical results with the vaccine
24. Statistical methods in microbiological researches
25. Experiences from vaccination and revaccination of teenage girls with three different rubella vaccines
26. Rubella vaccination in Australia: 2. Experience with the RA27/3 rubella vaccine and results of a double-blind trial in schoolgirls
27. Vaccination of adults with Wistar RA 27/3 rubella vaccine
28. Accuracy of rubella history
29. Exanthem subitum (roseola infantum) misdiagnosed as measles or rubella
30. Serological study of rubella-like illnesses
31. Human parvovirus B19 infections among exanthematic diseases notified as measles
32. Etiology of measles- and rubella-like illnesses in measles, mumps, and rubella-vaccinated children
33. Childhood exanthems old and new
34. Evaluation of rubella screening in pregnant women
35. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Burden of disease from CRS
36. A model-based evaluation of the national immunisation programme against rubella infection and congenital rubella syndrome in The Netherlands
37. Control of rubella and congenital rubella syndrome (CRS) in developing countries, Vaccination against rubella
38. The impact of rubella immunization on the incidence of rubella, congenital rubella syndrome and rubella-related terminations of pregnancy in South Australia
39. Incidence of congenital rubella syndrome and influence of the rubella vaccination program for schoolgirls in Japan, 1981-1989
40. Epidemic measles and rubella in Air Force recruits: Impact of immunization
41. Clinical efficacy of rubella vaccine